Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements
- 2021-02-25
- Clinical Trial
- Nutrients 13(3)
- Jessica L. Spears
- R. Kramer
- A. Nikiforov
- Marisa O. Rihner
- E. A. Lambert
- PubMed: 33668992
- DOI: 10.3390/nu13030733
- High evidence
In a 28 day human tolerability trial, 10 × 10^9 CFU/day of MB40 was well tolerated... Bacillus subtilis MB40 does not pose any human health concerns under the conditions tested.
- Effect
- Neutral
- Effect size
- Small